GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹1,025 Cr | ₹1,510 Cr | ₹1,302 Cr | ₹955 Cr | ₹955 Cr |
What is the latest Operating Profit of GLAND PHARMA ?
Year | Operating Profit |
---|---|
Mar2024 | ₹1,025 Cr |
Mar2023 | ₹1,510 Cr |
Mar2022 | ₹1,302 Cr |
Mar2021 | ₹955 Cr |
Mar2020 | ₹955 Cr |
How is Operating Profit of GLAND PHARMA Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,025 Cr | -32.14 | |
Mar2023 | ₹1,510 Cr | 15.97 | |
Mar2022 | ₹1,302 Cr | 36.29 | |
Mar2021 | ₹955 Cr | 0.00 | |
Mar2020 | ₹955 Cr | - |
Compare Operating Profit of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹25,583.6 Cr | 1.9% | 3.5% | -11.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,430.0 Cr | -3% | -8.7% | 4.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,410.0 Cr | -4.7% | -4.5% | 58.5% | Stock Analytics | |
CIPLA | ₹113,950.0 Cr | -4.3% | -3.2% | -3.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹99,682.3 Cr | -3% | -12.3% | 13.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,261.6 Cr | -3% | -6.5% | -12.7% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 1.9% |
3.5% |
-11.2% |
SENSEX | -3.4% |
-4.4% |
0.6% |
You may also like the below Video Courses